Suchergebnisse - "COVID-19"

PubPharm (94)

61

Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19 : Hemodynamic Effect of Prone Positioning in Non-intubated Patient With COVID 19 Pneumonia: a Monocentric Prospective Cohort Study

enthalten in: ClinicalTrials.gov | 2021

62

Vascular Abnormalities Detected With Chest CT in COVID-19 : Vascular Abnormalities Detected With Chest CT in COVID-19: Spectrum, Association With Other Lesions, and Correlation With Clinical Severity

enthalten in: ClinicalTrials.gov | 2021

63

Association Between Body Mass Index and HFNC Therapy Success : Association Between Body Mass Index and High-flow Cannula Therapy Success in Patients With Severe Covid 19 Related Pneumonia. Retrospective Study.

enthalten in: ClinicalTrials.gov | 2021

64

SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19 : SOLIRIS® (Eculizumab) for the Treatment of Participants With Coronavirus Disease 2019 (COVID 19) - An Expanded Access Program for Hospital-based Emergency Treatment

enthalten in: ClinicalTrials.gov | 2021

65

Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium, August to November 2020

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2021

von Ingelbeen, B. | Peckeu, L. | Laga, M. | +4

66

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial) : Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2

enthalten in: ClinicalTrials.gov | 2021

67

Chest CT Findings of COVID-19 Patients with Mild Clinical Symptoms at a Single Hospital in Korea

enthalten in: Taehan Yongsang Uihakhoe chi | 2021

von Baek, W. | Lee, Y. | Kim, S. | +4

68

Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 : A Phase 1/2 Open Label, Multicenter, Single Arm Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose Kamada Anti-SARS-CoV-2 in COVID-19 Hospitalized Patients With Pneumonia

enthalten in: ClinicalTrials.gov | 2021

69

Lung Lesion Burden found on Chest CT as a Prognostic Marker in Hospitalized Patients with High Clinical Suspicion of COVID-19 Pneumonia: a Brazilian experience

in: Clinics | 2021

von Eduardo Kaiser Ururahy Nunes Fonseca | Antonildes Nascimento Assunção Júnior | Jose de Arimateia Batista Araujo-Filho | +8

70

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection : A Randomized, Open-Label Study of the Efficacy and Safety of Aralast NP, an Alpha-1 Antitrypsin Infusion Therapy With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

enthalten in: ClinicalTrials.gov | 2020